Understanding emotional impulsivity in suicidal thoughts and behaviors
A Transdiagnostic Study of Emotional Impulsivity in Suicidal Ideation and Behavior
This study is looking at how feelings and quick decisions might affect thoughts about suicide in people with schizophrenia or major depression, using brain scans and surveys to better understand what’s happening in the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11139400 on NIH RePORTER |
What this research studies
This research investigates the connection between emotional impulsivity and suicidal ideation and behavior in individuals with schizophrenia spectrum disorder and major depressive disorder. By utilizing advanced brain imaging techniques and questionnaires, the study aims to identify specific brain regions and mechanisms that contribute to increased suicide risk. Participants will be assessed for their emotional responses and brain activity during tasks designed to measure impulsivity, providing insights into how these factors influence suicidal thoughts and actions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with schizophrenia spectrum disorder or major depressive disorder who experience suicidal thoughts or behaviors.
Not a fit: Patients without a diagnosis of schizophrenia spectrum disorder or major depressive disorder, or those who do not experience suicidal ideation or behavior, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies and interventions for individuals at risk of suicide.
How similar studies have performed: Previous research has shown promising results in understanding the relationship between emotional impulsivity and suicide risk, suggesting that this approach could yield valuable insights.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Hoptman, Matthew J — New York University School of Medicine
- Study coordinator: Hoptman, Matthew J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.